President Donald Trump unveils major cuts to weight-loss drug prices through new deals
The Trump administration announced price cuts for GLP-1 weight-loss drugs Zepbound and Wegovy, with direct-to-consumer access via TrumpRX in 2026. READ: https://www.usatoday.com/story/news/politics/2025/11/06/trump-medicare-coverage-weight-loss-drugs/87122843007/
US, Lilly, Novo to Announce Deal to Cut GLP-1 Prices (Trump’s Remarks)
Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. The deals with Lilly and Novo, announced Thursday at a White House event with President Donald Trump, will make some of the most popular drugs in the […]
Trump Reveals Temu Oddjob Is “Taking Fat Drugs”
The Daily Beast reports: Donald Trump has outed White House communications chief and resident attack dog Steven Cheung as a user of “fat drugs.” Announcing plans to slim down the cost of popular weight loss drugs, the president began naming his cabinet members and aides, asking if they needed such medication. “You taking any of […]
Trump makes deal to lower price of obesity drugs from Eli Lilly and Novo Nordisk
The Trump administration made a deal with pharmaceutical giants Eli Lilly and Novo Nordisk to lower prices for blockbuster anti-obesity and diabetes medications in the GLP-1 drug class, as well as expand coverage access for Medicare beneficiaries. The deal means the revolutionary drugs will be covered for Medicare patients struggling with obesity. Administration officials also […]
Trump unveils deal to lower prices for breakthrough weight-loss drugs
The deal could expand coverage and lower the price of GLP-1 medications for millions of Americans.
Trump unveils deal with Eli Lilly and Novo Nordisk to lower costs and expand coverage for obesity drugs
President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy. The drugs are part of a new generation of obesity medications known as GLP-1 receptor agonists that have soared in popularity in recent years. But access to […]
Pharmaceutical Rep Collapses in Oval Office During Trump Weight Loss Drug Press Conference | Video
A pharmaceutical rep collapsed in the Oval Office on Thursday right as Eli Lilly‘s David Ricks was discussing a weight loss drug deal during a press conference with President Donald Trump. “A representative with one of the companies fainted. The White House Medical Unit quickly jumped into action and the gentleman is okay,” Press Secretary Karoline Leavitt […]
President Trump unveils deal to expand coverage, lower costs on GLP-1 obesity drugs like Wegovy – News4JAX
President Trump unveils deal to expand coverage, lower costs on GLP-1 obesity drugs like Wegovy News4JAX
Some Patients Can Maintain Health Gains After Reducing GLP-1 Dose Frequency
(MedPage Today) — Patients with plateaued weight loss or who reached their weight-related goals on a GLP-1 receptor agonist were able to maintain their improvements in weight, body composition, and metabolic improvements after they reduced the…
Novo Nordisk Slides as GLP-1 Fatigue and Pricing Risks Cloud 2025 Outlook – Yahoo Finance
Novo Nordisk Slides as GLP-1 Fatigue and Pricing Risks Cloud 2025 Outlook Yahoo Finance Novo Nordisk CFO outlines ‘ultimate defense’ against stock downgrades and lawsuits to retain weight-loss crown Fortune Novo Nordisk Is Seeing Slowing Demand for GLP-1s Wegovy and Ozempic Yahoo Finance Novo Nordisk trims outlook as obesity drug maker loses ground to Eli Lilly Reuters After shaky […]